Johnson & Johnson (JNJ) begins on Tuesday its third attempt to push through a multi-billion-dollar settlement relating to ...

In a report released today, Josh Jennings from TD Cowen maintained a Buy rating on Johnson & Johnson (JNJ – Research Report), with a price ...

J&J JNJ stock has risen more than 6% in the past month. The reason behind the increase was a strong-than-expected ...

Johnson & Johnson is well-diversified across thriving healthcare segments, with promising FDA approvals. Read why I assign a ...

We recently compiled a list of the 13 Best Forever Stocks to Buy Right Now. In this article, we are going to take a look at ...

Bright Futures Wealth Management LLC. cut its holdings in Johnson & Johnson (NYSE:JNJ – Free Report) by 55.1% in the 4th ...

Equities researchers at Zacks Research lifted their Q2 2025 earnings estimates for Johnson & Johnson in a note issued to ...

Johnson & Johnson (NYSE: JNJ ... s top-selling drugs is now facing biosimilar competition, weighing on its stock price growth lately. If you want upside with a smoother ride than an individual ...

Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements. Johnson & Johnson is expected to post earnings ...

Johnson & Johnson is normally a good buy for its dividend and the stability it offers. Over the past five years, however, the ...

Johnson & Johnson (NYSE: JNJ) is one of the world's largest and most prominent healthcare leaders. Furthermore, revenue ...